{"id":"W2264090971","doi":"10.1016/j.kint.2015.11.026","title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","year":2016,"lang":"en","type":"article","venue":"Kidney International","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":294,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"Alexion Pharmaceuticals; American Society of Nephrology","keywords":"Eculizumab; Atypical hemolytic uremic syndrome; Medicine; Intensive care medicine; Thrombotic microangiopathy; Internal medicine; Immunology; Complement system; Antibody; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002285099,0.0001781498,0.0003420865,0.000148017,0.0001796319,0.0001515256,0.00009288206,0.0001989944,0.0006715392],"category_scores_gemma":[0.000696767,0.0000637846,0.0001651119,0.0001372895,0.0001376283,0.0002074418,0.0001256943,0.0003137292,0.0001127751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001513536,"about_ca_system_score_gemma":0.0002098647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002986834,"about_ca_topic_score_gemma":0.0006821163,"domain_scores_codex":[0.9998336,0.00006752068,0.00002442209,0.0000173683,0.00003788716,0.00001920792],"domain_scores_gemma":[0.9997534,0.00005242273,0.0001117561,0.000009349182,0.00002150905,0.00005158824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003799521,0.0007111168,0.4883778,0.0007821968,0.0002728952,0.01399877,0.0003691019,0.0006603164,0.0373971,0.0005605901,0.005321041,0.4477496],"study_design_scores_gemma":[0.001388658,0.0102035,0.8901449,0.000321274,0.0003453685,0.05205908,0.000347621,0.001584631,0.01337286,0.0003381214,0.02986913,0.00002491356],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9685816,0.02621806,0.00144319,0.0007592046,0.00005337386,0.00005341622,0.0001460823,0.00005784292,0.002687305],"genre_scores_gemma":[0.9938853,0.004362379,0.001100516,0.0002551383,0.00005386316,0.00002798552,0.0001217281,0.000003836604,0.0001892616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006715392,"threshold_uncertainty_score":0.002246499,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004381832449226359,"score_gpt":0.2181620525448668,"score_spread":0.2137802200956405,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}